Prostate cancer treatment with immunotherapy

Therapy activates the antitumor immunity of the patient. It implies the introduction of special biological agents. Its effectiveness is aimed at stopping the growth of a malignant neoplasm and activating the body's protective functions. Cytokine proteins (interleukins, interferons) are used to fight cancer. They have a complex effect on the tumor, blocking its nutrition and stopping growth. Monoclonal antibodies are usually administered as intravenous infusions. The introduction of inhibitors is also carried out by infusion, which – depending on the drug and tolerability – lasts from one to several hours and is repeated at regular intervals. Immunotherapy is usually combined with other methods and increases the effectiveness of complex treatment by 30-60%. Symptomatic therapy (antiemetics, painkillers, means to maintain the kidneys and liver functioning) copes well with undesirable reactions.